Systemic Therapies for Nonmetastatic Breast Cancer: The Role of Neoadjuvant and Adjuvant Chemotherapy and the Use of Endocrine Therapy

被引：3
|
作者：
Bychkovsky, Brittany L. [1 ,2 ]
Dizon, Don S. [2 ,3 ]
Sikov, William M. [4 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA USA
[3] Massachusetts Gen Hosp, Ctr Canc, 55 Fruit St, Boston, MA 02114 USA
[4] Brown Univ, Alpert Med Sch, Women & Infants Hosp Rhode Isl, Program Womens Oncol, Providence, RI 02912 USA
来源：
CLINICAL OBSTETRICS AND GYNECOLOGY | 2016年 / 59卷 / 04期
关键词：
breast cancer; chemotherapy; endocrine therapy; biological agents; adjuvant therapy; neoadjuvant therapy; PATHOLOGICAL COMPLETE REMISSION; CONTROLLED SUPERIORITY TRIAL; PACLITAXEL PLUS TRASTUZUMAB; PHASE-II TRIAL; OPEN-LABEL; COMPLETE RESPONSE; RANDOMIZED-TRIAL; FOLLOW-UP; STAGE-II; BEVACIZUMAB;
D O I：
10.1097/GRF.0000000000000237
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
Breast cancer is a heterogenous disease, comprised of at least 3 major subtypes: hormone receptor-positive/HER2-(HR+), HER2+, and HR-/HER2-(triple negative) breast cancers. The medical management of each subype is distinct. In this article, we review contemporary data supporting the use of chemotherapy, endocrine therapy and biologic therapies, especially HER2-directed agents, in the adjuvant and neoadjuvant setting in patients with newly diagnosed nonmetastatic (stage I-III) breast cancer.
引用
收藏
页码：756 / 771
页数：16
相关论文
共 50 条
  • [21] Role of radiation therapy on the use of primary ("neoadjuvant") systemic treatment of breast cancer
    Souchon, Rainer
    Dunst, J. rgen
    Hartmann, Karl Axel
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (04) : 202 - 209
  • [22] Outcomes of adjuvant endocrine therapy and hormone receptor status change following neoadjuvant chemotherapy in breast cancer patients
    Wu, Jia Yi
    Chen, Wei Guo
    Chen, Xiao Song
    Huang, Ou
    He, Jian Rong
    Zhu, Li
    Li, Yafen
    Shen, Kun Wei
    Chow, Louis W. C.
    Loo, Wings T. Y.
    Chow, Christopher Y. C.
    Tsang, William
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2014, 29 (04): : E380 - E386
  • [23] Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment
    Naoki Niikura
    Morihiko Kimura
    Takayuki Iwamoto
    Naoki Hayashi
    Junichi Shintoku
    Yuki Saito
    Yasuhiro Suzuki
    Yutaka Tokuda
    [J]. Breast Cancer, 2013, 20 : 67 - 74
  • [24] ADJUVANT SYSTEMIC THERAPY IN BREAST-CANCER .2. ADJUVANT CHEMOTHERAPY
    TIVER, KW
    BOYAGES, J
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1992, 62 (06): : 450 - 462
  • [25] Neoadjuvant Therapy in Nonmetastatic Breast Cancer in Kurdistan, Iraq
    Namiq, Karez Sarbast
    Sulaiman, Luqman Rahman
    [J]. JCO GLOBAL ONCOLOGY, 2023, 9 : e2200276
  • [26] Women Prefer Adjuvant Endocrine Therapy to Chemotherapy for Breast Cancer Treatment
    Niikura, N.
    Kimura, M.
    Iwamoto, T.
    Hayashi, N.
    Shintoku, J.
    Saito, Y.
    Suzuki, Y.
    Tokuda, Y.
    [J]. EUROPEAN JOURNAL OF CANCER, 2011, 47 : S268 - S269
  • [27] Women prefer adjuvant endocrine therapy to chemotherapy for breast cancer treatment
    Niikura, Naoki
    Kimura, Morihiko
    Iwamoto, Takayuki
    Hayashi, Naoki
    Shintoku, Junichi
    Saito, Yuki
    Suzuki, Yasuhiro
    Tokuda, Yutaka
    [J]. BREAST CANCER, 2013, 20 (01) : 67 - 74
  • [28] The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy
    Tal Sella
    Olga Kantor
    Anna Weiss
    Ann H. Partridge
    Otto Metzger
    Tari A. King
    [J]. Breast Cancer Research and Treatment, 2022, 194 : 663 - 672
  • [29] Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy
    O'Neil, Daniel S.
    Nietz, Sarah
    Buccimazza, Ines
    Singh, Urishka
    Cacala, Sharon
    Stopforth, Laura W.
    Joffe, Maureen
    Jacobson, Judith S.
    Neugut, Alfred, I
    Crew, Katherine D.
    Ruff, Paul
    Cubasch, Herbert
    [J]. ONCOLOGIST, 2019, 24 (07): : 933 - 944
  • [30] The prevalence and predictors of adjuvant chemotherapy use among patients treated with neoadjuvant endocrine therapy
    Sella, Tal
    Kantor, Olga
    Weiss, Anna
    Partridge, Ann H.
    Metzger, Otto
    King, Tari A.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (03) : 663 - 672
12345